Hind.Tin Works (530315)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trading below book value: P/B 0.88 against book value of ₹212.23
• Low P/E of 11.97 offers some earnings-based cushion
• Business remains profitable despite decline, with ₹2 Cr net profit in latest quarter
• Sales decline is modest at -1.16%, not a collapse
• Stock near 52-week high indicates some market confidence in a recovery

Concerns

• Profit growth down 21.82% with weak latest-quarter margin of roughly 2.3%
• ROE of 4.94% and ROCE of 7.95% show poor capital efficiency
• Piotroski F-Score of 3/9 suggests deteriorating financial fundamentals
• Dividend yield of just 0.67% offers little compensation while waiting for a turnaround

AI Analysis

Looking at Hind.Tin Works, I see a simple packaging business with a common problem—recent earnings are going backwards. Sales slipped 1.16% and profits fell 21.82%, with the latest quarter showing just ₹2 Cr of net profit on ₹88 Cr of sales, a thin margin. A Piotroski score of 3 out of 9 also tells me the financial health has deteriorated. That is not the kind of business that commands a wide moat. Packaging has competition and customers who can squeeze margins. Yet I notice the market is pricing this at ₹185.80 while the book value is ₹212.23, giving a price-to-book of 0.88. So I can buy a rupee of assets for 88 paise. But Graham insisted that a discount to book value only matters if the assets earn a decent return. Here ROE is just 4.94% and ROCE 7.95%, so the business is not earning its keep. If I buy for the assets, I need management to deploy them well or pay out the profits. The dividend yield of 0.67% is not very helpful. The stock is also at the top of its 52-week range, having doubled from ₹87.05, so the market is already expecting something better. With profit still falling, I would not chase it. I need to see clear evidence that margins are stabilizing and sales growth returns. If it can improve operations and keep its balance sheet sound, then the low P/E of 11.97 and cheap price-to-book may finally be justified. But right now, this is a low-return asset play, not a compounding machine. I would keep it on watch, not buy.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer